title: European drugs agency clashes with scientists over safety of GLP-1 drugs.
authors.forename: Deborah
authors.initials: D
authors.lastname: Cohen
mesh_terms: D003920:Diabetes Mellitus / Q000188:drug therapy*; D004345:Drug Industry; D005060:Europe; D052216:Glucagon-Like Peptide 1 / Q000009:adverse effects*; D006801:Humans; D054795:Incretins / Q000009:adverse effects*; D010182:Pancreatic Diseases / Q000139:chemically induced*
chemical_list: D054795:Incretins; D052216:Glucagon-Like Peptide 1